Clinical Trials Browser

Phase 2 × Carcinoma, Merkel Cell × Imatinib Mesylate × Clear all

NCT00068783 2013-02-28

S0331: Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Merkel Cell Cancer

Phase 2 Completed

Carcinoma, Merkel Cell